We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime (RASUNOA-Prime)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02533960
Recruitment Status : Completed
First Posted : August 27, 2015
Last Update Posted : November 2, 2022
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo, Inc.
University of Wuerzburg
Information provided by (Responsible Party):
Prof. Roland Veltkamp, University Hospital Heidelberg